NCT03398278View on ClinicalTrials.gov

OTR Tablet 40 mg Fasted-state Bioequivalence Study

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

June 30, 2017

Primary Completion Date

October 15, 2017

Study Completion Date

March 20, 2018

Conditions
Chronic Pain
Interventions
DRUG

Oxycodone Tamper Resistant

Orally taking Oxycodone Tamper Resistant 40mg in fast state

DRUG

OXYCONTIN®

Orally taking OXYCONTIN® 40mg in fast state

Trial Locations (1)

610041

West Hospital, Sichuan University, Chengdu

All Listed Sponsors
lead

Mundipharma (China) Pharmaceutical Co. Ltd

INDUSTRY

NCT03398278 - OTR Tablet 40 mg Fasted-state Bioequivalence Study | Biotech Hunter | Biotech Hunter